Cargando…

(2Z)-2-Fluoro-N-{4-[5-(4-fluoro­phen­yl)-2-methyl­sulfanyl-1H-imidazol-4-yl]-2-pyrid­yl}-3-phenyl­acrylamide

The asymmetric unit of the title compound, C(24)H(18)F(2)N(4)OS, contains two crystallographically independent mol­ecules, A and B, which are linked into two chains of A and B mol­ecules by inter­molecular N—H⋯O hydrogen bonds. The three-dimensional network is stabilized by π–π inter­actions between...

Descripción completa

Detalles Bibliográficos
Autores principales: Selig, Roland, Schollmeyer, Dieter, Stegmiller, Thomas, Albrecht, Wolfgang, Laufer, Stefan
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2971986/
https://www.ncbi.nlm.nih.gov/pubmed/21578977
http://dx.doi.org/10.1107/S1600536809051010
Descripción
Sumario:The asymmetric unit of the title compound, C(24)H(18)F(2)N(4)OS, contains two crystallographically independent mol­ecules, A and B, which are linked into two chains of A and B mol­ecules by inter­molecular N—H⋯O hydrogen bonds. The three-dimensional network is stabilized by π–π inter­actions between the pyridine rings and phenyl rings of different residues, with centroid–centroid distances of 3.793 (1) and 3.666 (2) Å. The mol­ecular conformation is stabilized by intra­molecular N—H⋯F hydrogen bonds (2.15/2.15Å). The imidazole rings make dihedral angles of 39.5 (2)/38.5 (2) and 31.8 (2)/33.2 (2)° with the 4-fluoro­phenyl rings and the pyridine rings, respectively. The methyl group of molecule A is disorderd in a 0.60:0.40 ratio.